FOXD2 and prostate cancer: Noteworthy, the only two studies of FOXD2 in humans are related to cancer; in one, a locus including the FOXD2 was found to be deleted in meningioma [26] and, in the other, the protein was found to be more highly expressed in prostate cancer and lymph node metastases compared to normal prostate [27].